Minovia Kicks Off Phase I/II Trial of Experimental Pearson Syndrome Treatment
According to a publication from Business Wire, the Israeli biotechnology company Minovia Therapeutics recently finished dosing the first participant in a phase I/II clinical study of the Company's experimental mitochondrial…